search
Back to results

Personalized Nutrition for Pre-Diabetes

Primary Purpose

Pre Diabetes

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Algorithm-based diet
Mediterranean-style low-fat diet
Sponsored by
Weizmann Institute of Science
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pre Diabetes focused on measuring Diabetes

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • HbA1C 5.7 - 6.4
  • Fasting Glucose 100 - 125 mg/dl
  • Age - 18-55
  • Capable of working with smartphone application

Exclusion Criteria:

  • Antibiotics/antifungal in the last 3 month
  • Use of anti-diabetic and/or weight-loss medication
  • People under another diet regime and/or a dietitian consultation/another study
  • Pregnancy, fertility treatments
  • Chronic disease (e.g. HIV, Cushing syndrome, CKD, acromegaly, hyperthyroidism etc.)
  • Cancer and recent anticancer treatment
  • Psychiatric disorders
  • Coagulation disorders
  • IBD (inflammatory bowel diseases)
  • Bariatric surgery
  • Alcohol or substance abuse

Sites / Locations

  • The Weizmann Institute of Science

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Algorithm-based diet

Mediterranean-style low-fat diet

Arm Description

Subjects randomized to this arm will receive personally tailored dietary recommendations based on their predicted glycemic responses according to the study algorithm.

Subjects randomized to this arm will receive nutritional recommendations according to the standard Israeli dietary approach for treating pre-diabetes: Mediterranean-style low-fat diet.

Outcomes

Primary Outcome Measures

Evaluation of the total daily time of plasma glucose levels below 140 mg/dl
Total daily plasma glucose levels will be evaluated by using a Continuous glucose monitoring (CGM)
Mean change in HbA1C from the baseline level
Difference of at least 0.1% in the reduction of HbA1C between control group and experimental group
Mean change in Glucose Tolerance Test from the baseline level
GTT glucose values (mg/dl)

Secondary Outcome Measures

Change is Fasting plasma glucose from baseline
Fasting glucose values (mg/dl)
Change in HOMA-IR from baseline
Change in insulin sensitivity from baseline to 6 months will be measured via HOMA-IR

Full Information

First Posted
July 13, 2017
Last Updated
April 21, 2020
Sponsor
Weizmann Institute of Science
search

1. Study Identification

Unique Protocol Identification Number
NCT03222791
Brief Title
Personalized Nutrition for Pre-Diabetes
Official Title
Personalized Nutrition for Pre-Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
February 1, 2017 (Actual)
Primary Completion Date
September 10, 2019 (Actual)
Study Completion Date
March 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weizmann Institute of Science

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The Personalized Nutrition Project for Prediabetes (PNP3) study will investigate whether personalized diet intervention will improve postprandial blood glucose levels and other metabolic health factors in individuals with prediabetes as compared with the standard low-fat diet.
Detailed Description
Blood glucose levels are rapidly increasing in the population, as evident by the sharp incline in the prevalence of prediabetes and impaired glucose tolerance estimated to affect, in the U.S. alone, 37% of the adult population. Chronic hyperglycaemia is a significant risk factor for type II diabetes mellitus (TIIDM), with up to 70% of prediabetics eventually developing the disease. It is also linked to other manifestations, collectively termed the metabolic syndrome, including obesity, hypertension, non-alcoholic fatty liver disease, hypertriglyceridemia and cardiovascular disease. As blood glucose levels are mainly affected by food consumption, the growing number of blood glucose abnormalities is likely attributable to nutrition. Indeed, dietary and lifestyle changes normalize blood glucose levels in 55% -80% of the cases. Therefore, maintaining normal blood glucose levels is critical for preventing diabetes and its metabolic complications. Currently, there are no effective methods for predicting the post prandial glycemic response (PPGR) of people to food. The current practice of using the meal carbohydrate content is a poor predictor of the PPGR and has limited efficacy.The glycemic index (GI), which quantifies PPGR to consumption of a single tested food type, and the derived glycemic load have limited applicability in assessing the PPGR to real-life meals consisting of arbitrary food combinations and varying quantities, consumed at different times of the day, and at different proximity to physical activity and other meals. Indeed, studies examining the effect of diets with a low glycemic index on TIIDM risk, weight loss, and cardiovascular risk factors yielded mixed results. The limited success of GI measure is probably due to the fact that it is a general index, which does not take into consideration the large variation between individuals in their glycemic response to food. It can be concluded, therefore, that in order to control glycemic response of an individual, a personalized tailored diet which takes into account various factors is required. Although genetic factors influence the levels of fasting blood glucose and glycemic response to food, these factors only explain approximately 10% of the variance in the population. Supporting this claim is the fact that the number of people with diabetes is increasing in recent years regardless of patients' genetic background. In contrast, environmental factors such as the composition of the intestinal bacteria and their metabolic activity may affect the glycemic response. The entire bacteria population in the digestive tract (microbiome) consist of ~1,000 species with a genetic repertoire of ~3 million different genes. The microbiome is directly affected by our diet and directly affect the body's response to food. This special relationship between the host and the intestinal flora is reflected by the composition of bacteria unique to type 2 diabetes and in the significant changes in the bacteria composition upon transition from a diet rich in fiber to a "Western" diet rich in simple sugars. The study is conducted to evaluate a highly accurate algorithm developed at the Weizmann Institute of Science for predicting the personalized glucose response to food for each person. The algorithm"s predictions are based on many personal measurements, including blood tests, personal lifestyle and gut bacteria. In a small-scale pilot study that was conducted using this algorithm, the investigators personally tailored dietary interventions to healthy and prediabetic people, which resulted in significantly improved PPGRs accompanied by consistent alterations to the gut microbiota. These findings led the investigators to hypothesize that tailoring personalized diets based on PPGRs predictions may achieve better outcomes in terms of controlling blood glucose levels and its metabolic consequences relative to the current standard nutritional therapy for prediabetes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pre Diabetes
Keywords
Diabetes

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
244 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Algorithm-based diet
Arm Type
Experimental
Arm Description
Subjects randomized to this arm will receive personally tailored dietary recommendations based on their predicted glycemic responses according to the study algorithm.
Arm Title
Mediterranean-style low-fat diet
Arm Type
Other
Arm Description
Subjects randomized to this arm will receive nutritional recommendations according to the standard Israeli dietary approach for treating pre-diabetes: Mediterranean-style low-fat diet.
Intervention Type
Other
Intervention Name(s)
Algorithm-based diet
Intervention Description
Personalized nutrition plan based on an algorithm for predicting the personalized glucose response to food. The algorithm's predictions are based on many personal measurements, including blood tests, personal lifestyle and gut bacteria.
Intervention Type
Other
Intervention Name(s)
Mediterranean-style low-fat diet
Intervention Description
The Israeli standard of care dietary guidelines for prediabetes.
Primary Outcome Measure Information:
Title
Evaluation of the total daily time of plasma glucose levels below 140 mg/dl
Description
Total daily plasma glucose levels will be evaluated by using a Continuous glucose monitoring (CGM)
Time Frame
6 months
Title
Mean change in HbA1C from the baseline level
Description
Difference of at least 0.1% in the reduction of HbA1C between control group and experimental group
Time Frame
6 months
Title
Mean change in Glucose Tolerance Test from the baseline level
Description
GTT glucose values (mg/dl)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change is Fasting plasma glucose from baseline
Description
Fasting glucose values (mg/dl)
Time Frame
6 months
Title
Change in HOMA-IR from baseline
Description
Change in insulin sensitivity from baseline to 6 months will be measured via HOMA-IR
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Patients compliance evaluation using a compliance questionnaire
Description
Follow up questionnaire completed independently by the patients
Time Frame
6 months, 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: HbA1C 5.7 - 6.4 Fasting Glucose 100 - 125 mg/dl Age - 18-55 Capable of working with smartphone application Exclusion Criteria: Antibiotics/antifungal in the last 3 month Use of anti-diabetic and/or weight-loss medication People under another diet regime and/or a dietitian consultation/another study Pregnancy, fertility treatments Chronic disease (e.g. HIV, Cushing syndrome, CKD, acromegaly, hyperthyroidism etc.) Cancer and recent anticancer treatment Psychiatric disorders Coagulation disorders IBD (inflammatory bowel diseases) Bariatric surgery Alcohol or substance abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eran Segal, Prof.
Organizational Affiliation
Weizmann Institute of Science
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Eran Elinav, MD
Organizational Affiliation
Weizmann Institute of Science
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Weizmann Institute of Science
City
Rehovot
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
34301736
Citation
Ben-Yacov O, Godneva A, Rein M, Shilo S, Kolobkov D, Koren N, Cohen Dolev N, Travinsky Shmul T, Wolf BC, Kosower N, Sagiv K, Lotan-Pompan M, Zmora N, Weinberger A, Elinav E, Segal E. Personalized Postprandial Glucose Response-Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes. Diabetes Care. 2021 Sep;44(9):1980-1991. doi: 10.2337/dc21-0162. Epub 2021 Jul 23.
Results Reference
derived

Learn more about this trial

Personalized Nutrition for Pre-Diabetes

We'll reach out to this number within 24 hrs